Practical applications of hormone replacement therapy (HRT) and testosterone replacement therapy (TRT) in women, including choosing the right options. The significant changes in testosterone levels over time in women. The role of compounding pharmacies in HRT and concerns about drug quality. Testing and diagnosing menopause, measuring hormone levels, and using anti-malarian hormone as a tool for evaluating ovarian reserve and fertility potential. Exploring menopausal symptoms and different hormone replacement therapies for relief.
Read more
AI Summary
Highlights
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Hormone replacement therapy (HRT) for women has been demonized in the past, but there is a need to understand its true impact on women's health.
Clinical diagnosis of menopause can be determined through amenorrhea and blood tests measuring FSH, LH, estradiol, and AMH, which are key factors to consider for hormone replacement therapy timing.
Deep dives
Overview of AMA episode on hormone replacement therapy
In this episode of the Drive podcast, the focus is on hormone replacement therapy (HRT) and testosterone replacement therapy (TRT) as it relates to women. The discussion centers around answering practical questions about the application of HRT and TRT for female patients. The conversation also explores the topic of compounding pharmacies and their role in hormone replacement therapy. The episode aims to provide insights and guidance on how to implement these therapies in practice.
Challenging the misconception around hormone replacement therapy
The host expresses frustration over the misinterpretation of the Women's Health Initiative and the subsequent demonization of hormone replacement therapy for women. He argues that the mainstream medical community has done a disservice to women by disregarding the benefits and potential harm caused by withholding hormone replacement therapy. The host asserts that the lack of HRT in the past 20 years has not led to any additional deaths from breast cancer, and emphasizes the importance of understanding the true impact of HRT on women's health.
Testing and diagnosing menopause and perimenopause
The episode discusses the clinical diagnosis of menopause, which requires 12 months of amenorrhea. Blood tests, specifically measuring follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol, can provide valuable insights into a woman's hormonal status and the likelihood of entering menopause. The decline of the anti-malarian hormone (AMH) is also mentioned as an additional test that may be useful in assessing ovarian reserve for women considering fertility. This discussion highlights the significance of these tests in determining the appropriate timing for hormone replacement therapy.
In this "Ask Me Anything" (AMA) episode, the discussion zeroed in on the practical application of hormone replacement therapy in women. Peter walks through the signs, symptoms, and hormonal changes in women approaching – and going through – menopause. He provides an overview of the FDA-approved HRT formulations and explains how women might go about choosing the right option for themselves. Peter also describes the significant changes in testosterone levels in women over time and the options, as well as the considerations and challenges of testosterone replacement therapy (TRT) for women. Lastly, Peter highlights the necessary role of compounding pharmacies in HRT, underscores concerns regarding the quality and sterility of compounded drugs, and offers guidance on locating a trustworthy pharmacy.
If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #52 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.
We discuss:
Why hormone replacement therapy is such an important topic [2:00];
The onset of menopause: symptoms, blood tests, and when to consider HRT [6:00];
Tests that may provide indications of perimenopause and their implications for fertility [9:15];
Vasomotor symptoms: hormonal changes that cause hot flashes/night sweats, and HRT therapies that can help [13:45];
The role of estrogen in menopausal HRT [17:30];
The limited role of progesterone in HRT protocols [25:15];
What is a “bioidentical” hormone? [28:30];
Overview of the FDA-approved HRT formulations [31:45];
Determining HRT dosing and considerations for perimenopausal women [37:45];
Choosing the right HRT formulation: pros and cons [43:30];
Examining the link between certain forms of estrogen and breast cancer [46:45];
Changes in testosterone levels in women over time and why it matters [50:00];
Recognizing low testosterone in women: common symptoms and diagnosis [53:45];
Testosterone replacement therapy for women: options, considerations, and challenges [57:30];
The long-term use of testosterone in women: examining the limited data [1:00:15];
What is a compounding pharmacy? [1:09:30];
Reasons to opt for a compounding pharmacy over a pharmacy that adheres to stricter regulations [1:16:00];
The tragic incidents that heightened concerns about compounding pharmacies [1:20:45];
Tips for finding a reputable compounding pharmacy [1:27:45]; and